No leadership without a change of course: Belgium at a turning point for innovative biopharma

Innovative biopharma has long been a driver of growth, employment, exports and innovation, but today we are seeing a turning point.

For many years, Belgium has been able to position itself as a leader in pharma and life sciences – not thanks to natural resources or rare raw materials, but to knowledge, talent and a strong culture of innovation. The core political and economic rationale was that, as a small, open economy, we must excel in innovation. Today, we must acknowledge that this very foundation is coming under pressure.